Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment?

Crabb Simon J.

首页> 外文期刊>European urology >Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment?

【24h】

Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment?

机译：针对晚期尿路上皮癌的个性化药物：识别合适患者的正确治疗方法是什么？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第6期|共2页
作者
Crabb Simon J.;
展开▼
作者单位

Univ Southampton Canc Sci Unit Southampton Hants England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment? [J] . Crabb Simon J. European urology . 2019,第6期

机译：针对晚期尿路上皮癌的个性化药物：识别合适患者的正确治疗方法是什么？
2. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment [J] . Songbai Wang, Mike Burgess, Christopher Major, The Journal of Pathology: Clinical Research . 2020,第3期

机译：鉴定使用RNA的测定在转移或局部晚期，手术不可切除的尿路上皮癌患者中使用RNA的测定，核癌癌的成纤维细胞生长因子受体遗传改变
3. A Real-World Data Study to Evaluate Treatment Patterns, Clinical Characteristics and Survival Outcomes for First- and Second-Line Treatment in Locally Advanced and Metastatic Urothelial Cancer Patients in Germany [J] . Günter Niegisch, Holger Gerullis, Shih-Wen Lin, Journal of Cancer . 2018,第8期

机译：实际数据研究，以评估德国局部晚期和转移性尿道癌患者的一线和二线治疗的治疗方式，临床特征和生存结局
4. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT [C] . VLADIMIR GLIGORIJEVIó, NOEL MALOD-DOGNIN, NATASA PRZULJ Pacific Symposium on Biocomputing . 2016

机译：患者特异性数据融合，用于癌症分层和个性化治疗
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol [O] . Emma Clark, Miranda Morton, Shriya Sharma, 2019

机译：前列腺癌雄激素受体剪接变体7生物标志物研究-生物标志物指导的个性化治疗晚期前列腺癌患者的多中心随机可行性试验（VARIANT试验）研究方案
7. PCN339 - SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER): TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN THE UNITED STATES [O] . G. Doshi, A. Bhanegaonkar, M. Bharmal, 2018

机译：PCN339 - 矛膀胱（关于膀胱癌的治疗途径决定的研究）：在美国社区肿瘤学患者患者患者中的一线治疗后治疗时间

Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment?

著录项

相似文献

相关主题

期刊订阅